Chapa, MD, University of Nebraska Medical Center, brings awareness to the racial disparities demonstrated in his ...

Post-transplant, columnist Sam Kirton avoids negativity at all costs, as it's detrimental to his mental health and overall well-being.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Two posters presented at CHEST 2024 revealed significant racial and ethnic disparities in the hospitalization and treatment ...

Novartis halted its Phase II IPF trial for LTP001, citing non-safety reasons. This move aligns with its strategy to ...

IPF treatment SM001-055 was generally safe and improved lung function, according to top-line data from a Phase 2a trial.

Novartis has terminated a phase 2 trial of its SMURF1 inhibitor LTP001 in idiopathic pulmonary fibrosis (IPF) but will ...

In propensity score-matched cohorts of 121,046 hospitalized patients, those with RA and T2D had an ILD prevalence of 2.25%, ...

Princess Mette-Marit of Norway will curtail her duties temporarily to undergo further treatment for chronic pulmonary fibrosis, the Norwegian royal palace has confirmed.

It will be Band of Builders' third project in Northern Ireland - but they need more volunteers to make it a reality ...

Paul W. Noble, M.D., of Cedars-Sinai in Los Angeles, and Paul Frohna, M.D., Ph.D., of Endeavor BioMedicines, discussed the ...

About GRI Bio, Inc. GRI Bio is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI Bio’s therapies are ...